0000899140-23-001108.txt : 20231114 0000899140-23-001108.hdr.sgml : 20231114 20231114163020 ACCESSION NUMBER: 0000899140-23-001108 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 EFFECTIVENESS DATE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sarissa Capital Management LP CENTRAL INDEX KEY: 0001577524 IRS NUMBER: 900924432 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15935 FILM NUMBER: 231406941 BUSINESS ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203-302-2330 MAIL ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001577524 XXXXXXXX 09-30-2023 09-30-2023 false Sarissa Capital Management LP
660 STEAMBOAT ROAD GREENWICH CT 06830
13F HOLDINGS REPORT 028-15935 N
Alexander J. Denner, Ph.D. Chief Investment Officer 203-302-2330 /s/ Alexander J. Denner Greenwich CT 11-14-2023 0 11 742379576
INFORMATION TABLE 2 informationtable.xml ALKERMES PLC SHS G01767105 197252022 7042200 SH SOLE 7042200 0 0 AMARIN CORP PLC SPONS ADR NEW 023111206 9607057 10442453 SH SOLE 10442453 0 0 BIOCRYST PHARMACEUTICALS INC COM 09058V103 5487000 775000 SH SOLE 775000 0 0 BIOGEN INC COM 09062X103 165257430 643000 SH SOLE 643000 0 0 GILEAD SCIENCES INC COM 375558103 68974776 920400 SH SOLE 920400 0 0 INNOVIVA INC COM 45781M101 94528230 7277000 SH SOLE 7277000 0 0 IRONWOOD PHARMACEUTICALS INC COM CL A 46333X108 157835700 16390000 SH SOLE 16390000 0 0 MERSANA THERAPEUTICS INC COM 59045L106 698500 550000 SH SOLE 550000 0 0 NEUROCRINE BIOSCIENCES INC COM 64125C109 41175000 366000 SH SOLE 366000 0 0 REGULUS THERAPEUTICS INC COM 75915K309 253701 185183 SH SOLE 185183 0 0 VOR BIOPHARMA INC COM 929033108 1310160 618000 SH SOLE 618000 0 0